See also this year's filing and all EDGAR filings for this company.
PDF Report 0001595262_2016_IMS_Health_Holdings_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001595262')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001595262, IMS Health Holdings Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,092,000,000 |
| 1 | AssetsNonCurrent | 276,000,000 |
| 2 | IntangibleAssets | 5,782,000,000 |
| 3 | remainder_Assets | 309,000,000 |
| 4 | LiabilitiesCurrent | 1,033,000,000 |
| 5 | LiabilitiesNonCurrent | 4,219,000,000 |
| 6 | remainder_Liabilities | 635,000,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingExpense | 712,000,000 |
| 9 | GeneralAndAdministrativeExpense | 0 |
| 10 | ResearchAndDevelopment | 0 |
| 11 | DepreciationDepletionAndAmortization | 341,000,000 |
| 12 | remainder_Expenses | 1,304,000,000 |
| 13 | remainder_Revenues | 2,921,000,000 |
| 14 | remainder_NetIncome | -147,000,000 |
| 15 | remainder_ComprehensiveNetIncome | -133,000,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 7,459,000,000 |
| 1 | Liabilities | 5,887,000,000 |
| 2 | Expenses | 2,357,000,000 |
| 3 | Revenues | 2,921,000,000 |
| 4 | StockholdersEquity | 1,572,000,000 |
| 5 | NetIncome | 417,000,000 |
| 6 | ComprehensiveNetIncome | 284,000,000 |
| 7 | BaseVar | 9,452,000,000 |
| 8 | EconomicCapitalRatio | 0.323 |